Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma. | Hum Pathol | 2023 | 37586462 | PubTator, text mining | PubMed |
| Bioinformatics-based screening of key genes for transformation of tyrosine kinase inhibitor-resistant lung adenocarcinoma to small cell lung cancer. | Front Med (Lausanne) | 2023 | 37583423 | PubTator, text mining | PubMed |
| A single-cell atlas of in vitro multiculture systems uncovers the in vivo lineage trajectory and cell state in the human lung. | Exp Mol Med | 2023 | 37582976 | PubTator, text mining | PubMed |
| NeuroD4 converts glioblastoma cells into neuron-like cells through the SLC7A11-GSH-GPX4 antioxidant axis. | Cell Death Discov | 2023 | 37582760 | PubTator, text mining | PubMed |
| The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2. | Int J Mol Sci | 2023 | 37569398 | PubTator, text mining | PubMed |
| DNA methylation networks underlying mammalian traits. | Science | 2023 | 37561875 | PubTator, text mining | PubMed |
| Single-cell analysis reveals region-heterogeneous responses in rhesus monkey spinal cord with complete injury. | Nat Commun | 2023 | 37558705 | PubTator, text mining | PubMed |
| ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer. | Cell Rep | 2023 | 37552603 | PubTator, text mining | PubMed |
| Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects. | Onco Targets Ther | 2023 | 37551311 | PubTator, text mining | PubMed |
| The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer. | Cancer Res Commun | 2023 | 37546702 | PubTator, text mining | PubMed |
| Inhibition of EZH2 alleviates SAHA-induced senescence-associated secretion phenotype in small cell lung cancer cells. | Cell Death Discov | 2023 | 37543653 | PubTator, text mining | PubMed |
| Methylation testing for the detection of recurrent cervical intraepithelial neoplasia. | Int J Cancer | 2023 | 37539971 | PubTator, text mining | PubMed |
| DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis. | Clin Epigenetics | 2023 | 37533074 | PubTator, text mining | PubMed |
| Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy. | JTO Clin Res Rep | 2023 | 37529402 | PubTator, text mining | PubMed |
| Quantifying common and distinct information in single-cell multimodal data with Tilted Canonical Correlation Analysis. | Proc Natl Acad Sci U S A | 2023 | 37523521 | PubTator, text mining | PubMed |
| Genome-wide Association Studies of REST Gene Associated Neurological Diseases/traits with Related Single Nucleotide Polymorphisms. | Curr Neurovasc Res | 2023 | 37518996 | PubTator, text mining | PubMed |
| Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3' untranslated region mutations. | Cell Rep | 2023 | 37516102 | PubTator, text mining | PubMed |
| CASZ1: Current Implications in Cardiovascular Diseases and Cancers. | Biomedicines | 2023 | 37509718 | PubTator, text mining | PubMed |
| Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives. | Biomedicines | 2023 | 37509621 | PubTator, text mining | PubMed |
| Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance. | Cancers (Basel) | 2023 | 37509231 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=30